Literature DB >> 10605021

Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130.

I Kurth1, U Horsten, S Pflanz, A Timmermann, A Küster, H Dahmen, I Tacken, P C Heinrich, G Müller-Newen.   

Abstract

The transmembrane glycoprotein gp130 is the common signal transducing receptor subunit of the IL-6-type cytokines. The gp130 extracellular part is predicted to consist of six individual domains. Whereas the role of the three membrane-distal domains (D1-D3) in binding of IL-6 and IL-11 is well established, the function of the membrane-proximal domains (D4-D6) is unclear. Mapping of a neutralizing mAb to the membrane-proximal part of gp130 suggests a functional role of D4-D6 in receptor activation. Individual deletion of these three domains differentially interferes with ligand binding of the soluble and membrane-bound receptors. All deletion mutants do not signal in response to IL-6 and IL-11. The deletion mutants Delta4 and, to a lesser extent, Delta6 are still activated by agonistic monoclonal gp130 Abs, whereas the deletion mutant Delta5 does not respond. Because membrane-bound Delta5 binds IL-6/soluble IL-6R as does wild-type gp130, but does not transduce a signal in response to various stimuli, this domain plays a prominent role in coupling of ligand binding and signal transduction. Replacement of the fifth domain of gp130 by the corresponding domain of the homologous G-CSF receptor leads to constitutive activation of the chimera upon overexpression in COS-7 cells. In HepG2 cells this mutant responds to IL-6 comparable to wild-type gp130. Our findings suggest a functional role of the membrane-proximal domains of gp130 in receptor activation. Thus, within the hematopoietic receptor family the mechanism of receptor activation critically depends on the architecture of the receptor ectodomain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10605021     DOI: 10.4049/jimmunol.164.1.273

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes.

Authors:  Yibin Xu; Nadia J Kershaw; Cindy S Luo; Priscilla Soo; Michael J Pocock; Peter E Czabotar; Douglas J Hilton; Nicos A Nicola; Thomas P J Garrett; Jian-Guo Zhang
Journal:  J Biol Chem       Date:  2010-05-20       Impact factor: 5.157

2.  Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.

Authors:  Christiane Stuhlmann-Laeisz; Sigrid Lang; Athena Chalaris; Paliga Krzysztof; Sudarman Enge; Jutta Eichler; Ursula Klingmüller; Michael Samuel; Matthias Ernst; Stefan Rose-John; Jürgen Scheller
Journal:  Mol Biol Cell       Date:  2006-04-19       Impact factor: 4.138

Review 3.  Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function.

Authors:  Esther van de Vosse; Elgin G R Lichtenauer-Kaligis; Jaap T van Dissel; Tom H M Ottenhoff
Journal:  Immunogenetics       Date:  2003-02-21       Impact factor: 2.846

4.  Signal transducer gp130: biochemical characterization of the three membrane-proximal extracellular domains and evaluation of their oligomerization potential.

Authors:  S Pflanz; T Kernebeck; B Giese; A Herrmann; M Pachta-Nick; J Stahl; A Wollmer; P C Heinrich; G Müller-Newen; J Grötzinger
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

Review 5.  Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.

Authors:  Lindsay L Jones; Dario A A Vignali
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

6.  Forced homo- and heterodimerization of all gp130-type receptor complexes leads to constitutive ligand-independent signaling and cytokine-independent growth.

Authors:  Jan Suthaus; Anna Tillmann; Inken Lorenzen; Elena Bulanova; Stefan Rose-John; Jürgen Scheller
Journal:  Mol Biol Cell       Date:  2010-06-16       Impact factor: 4.138

7.  Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis.

Authors:  Ming-Wei Lin; Ding-Dar Lee; Tze-Tze Liu; Yong-Feng Lin; Shang-Yi Chen; Chih-Cheng Huang; Hui-Ying Weng; Yu-Fen Liu; Akio Tanaka; Ken Arita; Joey Lai-Cheong; Francis Palisson; Yun-Ting Chang; Chu-Kwan Wong; Isao Matsuura; John A McGrath; Shih-Feng Tsai
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

Review 8.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

Authors:  Peter C Heinrich; Iris Behrmann; Serge Haan; Heike M Hermanns; Gerhard Müller-Newen; Fred Schaper
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

9.  Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis.

Authors:  Ken Arita; Andrew P South; Günter Hans-Filho; Thais Harumi Sakuma; Joey Lai-Cheong; Suzanne Clements; Maçanori Odashiro; Danilo Nakao Odashiro; Günter Hans-Neto; Nelise Ritter Hans; Maxine V Holder; Balbir S Bhogal; Sian T Hartshorne; Masashi Akiyama; Hiroshi Shimizu; John A McGrath
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

10.  N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130.

Authors:  Georg H Waetzig; Athena Chalaris; Philip Rosenstiel; Jan Suthaus; Christin Holland; Nadja Karl; Lorena Vallés Uriarte; Andreas Till; Jürgen Scheller; Joachim Grötzinger; Stefan Schreiber; Stefan Rose-John; Dirk Seegert
Journal:  J Biol Chem       Date:  2009-11-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.